COHEN DORON LEIB enters GALMED PHARMACEUTICALS LTD. with 72.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001493152-26-010846
Officer· Chief Financial Officer
Since Mar 2026
72.50K
Baseline shares
100% direct
72.50K
Direct ownership
4 positions
208.00
Derivative underlying
1 instrument
4
Security positions
All direct
Non-Derivative Holdings4
Restricted Share Units
DirectShares owned25K
Restricted Share Units
DirectShares owned23.33K
Ordinary Shares
DirectShares owned22.08K
Restricted Share Units
DirectShares owned2.08K
Total
72.50K direct72.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Share Units | 25K | Direct |
| Restricted Share Units | 23.33K | Direct |
| Ordinary Shares | 22.08K | Direct |
| Restricted Share Units | 2.08K | Direct |
| Total | 72.50K | 72.50K direct |
Derivative Holdings1
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
208.00
Shares owned
N/A
Exercise price
68.40
Expiration
—
Exercise window
—
Total
Underlying
208.00
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 68.40 | — | — | 208.00 | N/A |
| Total | 208.00 | 0.00 | ||||